| LIRRX | TRWTX | LIRRX / TRWTX | |
| Total Expense Ratio | 1.24 | 0.76 | 163% |
| Annual Report Gross Expense Ratio | 1.24 | 0.76 | 163% |
| Fund Existence | 17 years | 33 years | - |
| Gain YTD | 25.439 | 21.799 | 117% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 455M | 4.28B | 11% |
| Annual Yield % from dividends | 2.59 | 2.19 | 118% |
| Returns for 1 year | 24.12 | 20.34 | 119% |
| Returns for 3 years | 56.12 | 45.46 | 123% |
| Returns for 5 years | 52.00 | 49.01 | 106% |
| Returns for 10 years | 68.75 | 70.29 | 98% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FMED | 27.76 | 0.52 | +1.91% |
| Fidelity Disruptive Medicine ETF | |||
| DHS | 100.80 | 1.43 | +1.44% |
| WisdomTree US High Dividend ETF | |||
| AMZY | 13.17 | 0.17 | +1.31% |
| YieldMax AMZN Option Income Strategy ETF | |||
| PSTR | 28.27 | 0.25 | +0.89% |
| PeakShares Sector Rotation ETF | |||
| GBXC | 26.50 | 0.15 | +0.57% |
| Goldman Sachs U.S. Lg Cp Buffr 3 ETF | |||